S100A14 and breast cancer: The overexpression of S100A14 is related with poor prognoses in breast cancer, liver cancer, cervical cancer and ovarian cancer [13, 31, 33–36] but is associated with favorable outcomes in colorectal and small intestinal cancers [37, 38].